https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730467 Mon, 27 Apr 2026 08:00:00 -0400 https://www.bioworld.com/articles/730467-pleased-to-own-ya-kelonia-lillys-7b-car-t-deal Gold-encircled handshake http://www.bioworld.com/articles/730495 Wed, 22 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730495-walking-the-talk-kyverna-phase-ii-stiffens-miv-cel-car-t-case Woman stretching her arms and hands http://www.bioworld.com/articles/730423 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730423-oricell-raises-110m-in-pre-ipo-round-to-advance-solid-tumor-car-ts Liver anatomy on medical background http://www.bioworld.com/articles/730278 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730278-mrd-word-heard-loud-clear-in-allogene-lbcl-cema-cel-phase-ii Art concept for hematologic cancer http://www.bioworld.com/articles/730221 Fri, 10 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730221-oricell-raises-110m-in-pre-ipo-round-to-advance-solid-tumor-car-ts Liver anatomy on medical background http://www.bioworld.com/articles/729289 Tue, 03 Mar 2026 12:00:00 -0500 https://www.bioworld.com/articles/729289-quell-delivers-first-data-showing-tregs-prevent-liver-transplant-rejection Illustration of a T cell http://www.bioworld.com/articles/729179 Mon, 23 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729179-gilead-brings-arcellx-fully-under-the-fold-for-78b Acquisition puzzle http://www.bioworld.com/articles/728700 Mon, 09 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728700-lilly-buying-car-t-firm-orna-in-24b-deal RNA illustration http://www.bioworld.com/articles/728232 Tue, 20 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/728232-early-data-lift-immunofocos-solid-tumor-car-t-program Stomach and esophagus http://www.bioworld.com/articles/728133 Tue, 20 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/728133-astrazeneca-expands-china-cell-therapy-footprint-with-abelzeta-car-t Liver over digital lens background http://www.bioworld.com/articles/728016 Fri, 16 Jan 2026 07:00:00 -0500 https://www.bioworld.com/articles/728016-immunitybios-car-nk-shows-complete-responses-in-waldenstroms Natural killer cell attacking cancer cell http://www.bioworld.com/articles/727892 Wed, 14 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/727892-early-data-lift-immunofocos-solid-tumor-car-t-program Stomach and esophagus http://www.bioworld.com/articles/727883 Tue, 13 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/727883-oricell-raises-70m-series-c-to-advance-china-developed-car-ts 3D rendering of CAR T therapy in cell http://www.bioworld.com/articles/726795 Tue, 02 Dec 2025 00:00:00 -0500 https://www.bioworld.com/articles/726795-myrio-first-to-develop-binders-with-high-affinity-specificity Illustration of cancer tumor http://www.bioworld.com/articles/726766 Wed, 26 Nov 2025 12:00:00 -0500 https://www.bioworld.com/articles/726766-myrio-first-to-develop-binders-with-high-affinity-specificity Illustration of cancer tumor http://www.bioworld.com/articles/726511 Wed, 26 Nov 2025 12:00:00 -0500 https://www.bioworld.com/articles/726511-myrio-first-to-develop-binders-with-high-affinity-specificity Illustration of cancer tumor http://www.bioworld.com/articles/726264 Wed, 19 Nov 2025 12:00:00 -0500 https://www.bioworld.com/articles/726264-tempest-gains-car-ts-for-65-of-the-company-stock-drops Red CAR T cell on blue blackground http://www.bioworld.com/articles/726096 Mon, 10 Nov 2025 12:00:00 -0500 https://www.bioworld.com/articles/726096-lyell-loves-it-ict-phase-i-mcrc-prospect-floats-license-deal http://www.bioworld.com/articles/726143 Mon, 10 Nov 2025 09:00:00 -0500 https://www.bioworld.com/articles/726143-azalea-exits-stealth-to-develop-its-in-vivo-gene-engineering-technology CRISPR Cas9 illustration CRISPR. Credit: Ernesto del Aguila III, National Human Genome Research Institute, NIH http://www.bioworld.com/articles/725878 Thu, 06 Nov 2025 10:00:00 -0500 https://www.bioworld.com/articles/725878-azalea-exits-stealth-to-develop-its-in-vivo-gene-engineering-technology CRISPR Cas9 illustration CRISPR. Credit: Ernesto del Aguila III, National Human Genome Research Institute, NIH http://www.bioworld.com/articles/724986 Fri, 10 Oct 2025 11:00:00 -0400 https://www.bioworld.com/articles/724986-car-ts-for-autoimmune-ramp-up-bms-buying-orbital-for-15b CAR T cell with implanted gene strand http://www.bioworld.com/articles/724564 Tue, 23 Sep 2025 11:00:00 -0400 https://www.bioworld.com/articles/724564-carsgens-zevor-cel-car-t-shows-long-term-survival-in-mm Multiple myeloma illustration http://www.bioworld.com/articles/724301 Thu, 18 Sep 2025 11:00:00 -0400 https://www.bioworld.com/articles/724301-carsgens-zevor-cel-car-t-shows-long-term-survival-in-mm Multiple myeloma illustration http://www.bioworld.com/articles/724327 Tue, 16 Sep 2025 11:00:00 -0400 https://www.bioworld.com/articles/724327-hong-kong-biotech-sector-back-on-track-with-13-growth BIO HK opening ceremony Opening ceremony of BIO Hong Kong 2025. http://www.bioworld.com/articles/723946 Wed, 10 Sep 2025 11:00:00 -0400 https://www.bioworld.com/articles/723946-hong-kong-biotech-sector-back-on-track-with-13-growth BIO HK opening ceremony Opening ceremony of BIO Hong Kong 2025. http://www.bioworld.com/articles/723155 Tue, 12 Aug 2025 11:00:00 -0400 https://www.bioworld.com/articles/723155-is-apac-ready-for-precision-medicine Precision targeted therapy concept illustrated by dart hitting bullseye of target http://www.bioworld.com/articles/722810 Wed, 06 Aug 2025 11:00:00 -0400 https://www.bioworld.com/articles/722810-is-apac-ready-for-precision-medicine Precision targeted therapy concept illustrated by dart hitting bullseye of target http://www.bioworld.com/articles/722605 Wed, 30 Jul 2025 11:00:00 -0400 https://www.bioworld.com/articles/722605-galapagos-does-an-about-face-on-cell-therapy-small-molecule-plans Cancer cell, dropper, test tubes BioWorld.]]> http://www.bioworld.com/articles/722248 Tue, 15 Jul 2025 11:00:00 -0400 https://www.bioworld.com/articles/722248-circode-applies-circrna-to-heart-disease-drug-r-and-d-in-vivo-car-t Circode executives From left to right: Circode’s Yun Yang, cofounder, chairman and chief technology officer; Zefeng Wang, scientific founder; and Chenxiang Tang, CEO. http://www.bioworld.com/articles/722152 Tue, 15 Jul 2025 11:00:00 -0400 https://www.bioworld.com/articles/722152-imugenes-allogeneic-cd19-car-t-sees-75-response-rate 3D rendering of CAR T therapy in cell